This weekend, I had the pleasure of being a guest on Peoples Pharmacy, a great public radio show that hails out of Durham NC. We had a far ranging, rapidly shifting conversation about lots of things. Check it out if you are interested. The show even gave me a chance to learn a new skill. I have a nasty little virus, and by the end of the show I had mastered what radio people call the cough button!
Angie Fagerlin—friend, colleague, and all around inspiration—just took the lead in a paper that is getting some media attention. (She was kind enough to include me in the effort.) The paper gives advice to cancer patients about how to make better decisions. This link shows CBS News’s take on it. (Is “News’s” a word?)
And if you want to see the article Angie wrote, it is here.
A bunch of media outlets are beginning to report on a new study of mine (conducted with a couple of great colleagues) in which we found that docs choose different treatments for themselves than they recommend to their patients. Kinda scary stuff. This Marketplace report is worth listening to. Check out the ‘News and Press’ page for links to some of the other reports.
Jay Singh had a nasty head cold. Not a “will-I-survive-this-plague” kind of infection, but also not one he thought, if left to its own devices, would blow over in a day or two. So he went to the primary care clinic near his exurban New York City home. The doctor spent ten minutes examining and…
Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.
Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.
Why these enormous price differences?
Brian Zikmund-Fisher took the lead on a study published this week in which we found evidence that when people face tough decisions, it helps for them to break the decision into smaller pieces, and take it one step at a time. Here is a link to some media coverage in India.
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.